Compare · COO vs RXST
COO vs RXST
Side-by-side comparison of The Cooper Companies Inc. (COO) and RxSight Inc. (RXST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both COO and RXST operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- COO is the larger of the two at $19.03B, about 71.5x RXST ($266.2M).
- RXST has hit the wire 5 times in the past 4 weeks while COO has been quiet.
- Both have 25 recent analyst ratings on file.
- Company
- The Cooper Companies Inc.
- RxSight Inc.
- Price
- -
- -
- Market cap
- $19.03B
- $266.2M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 0
- 5
- Recent ratings
- 25
- 25
The Cooper Companies Inc.
The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through two segments, CooperVision and CooperSurgical. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services for enhancing health of women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (OB/GYNs) medical offices, and fertility clinics. In addition, the company develops mechanical surgical solutions for skin closure; and offers PARAGARD, a contraceptive, as well as provides assisted reproductive technology products, genetic screening and testing, and products within the general OB/GYN offerings. It markets its products under Biofinity, clariti 1day, MyDay, Avaira Vitality, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, eye care practitioners, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in San Ramon, California.
RxSight Inc.
RxSight, Inc., a medical technology company, develops light adjustable lens (LAL) to improve uncorrected visual acuity that can be adjusted enhance uncorrected visual acuity after cataract surgery. It also offers RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is based in Aliso Viejo, California.
Latest COO
- CooperCompanies Announces Release Date for Third Quarter 2026
- UBS initiated coverage on Cooper with a new price target
- SEC Form 4 filed by Director Keel Paul A
- SEC Form 3 filed by new insider Keel Paul A
- CooperSurgical Supports Saving Mothers to Help Advance Global Women’s Health and Raise Awareness
- CooperCompanies Releases 2025 Corporate Sustainability Report with Scope 3 Emissions Disclosure
- SEC Form 10-Q filed by The Cooper Companies Inc.
- Needham reiterated coverage on Cooper with a new price target
- SEC Form 8-K filed by The Cooper Companies Inc.
- CooperCompanies Announces Second Quarter 2026 Results
Latest RXST
- Amendment: SEC Form SC TO-I/A filed by RxSight Inc.
- SEC Form SC TO-I filed by RxSight Inc.
- SEC Form 10-Q filed by RxSight Inc.
- RxSight Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook
- RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
- SEC Form 4 filed by President and CEO Mottiwala Aziz
- SEC Form 3 filed by new insider Mottiwala Aziz
- SEC Form S-8 filed by RxSight Inc.
- RxSight Inc. filed SEC Form 8-K: Regulation FD Disclosure